Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,643 across all filing types
Latest filing 2009-10-06 Transaction in Own Shar…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' submitted to the ASX. It details the number of shares bought back, total consideration paid, participation by directors, and remaining shares to be bought back. It includes compliance statements and is signed by the CFO. The document is short (2212 characters) and focuses solely on reporting share buy-back activity, which aligns with the definition of a Transaction in Own Shares (POS) filing. It is not an announcement of a report, nor does it contain financial statements or broader financial data. Therefore, the correct classification is POS.
2009-10-06 English
SOM: Welcomes ResMed`s entry into oral appliance market 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a press release dated 6th October 2009 from SomnoMed Limited announcing and welcoming ResMed's acquisition of a French dental company and entry into the oral appliance market. It discusses strategic business developments and market positioning rather than financial results, regulatory filings, or shareholder meeting materials. There are no financial statements, earnings data, or regulatory compliance information. The content is focused on a corporate announcement about market competition and product information. This fits best under the category of a general regulatory announcement or corporate news that does not fit other specific categories, thus classified as Regulatory Filings (RNS). The document length is about 4900 characters, which is not extremely short, but the content is clearly an announcement rather than a report or presentation.
2009-10-05 English
ResMed acquires Laboratoires Narval 2 pages ?Kb
M&A Activity Classification · 95% confidence The document is a press release announcing ResMed's acquisition of Laboratoires Narval. It describes the acquisition details, the products involved, and the strategic rationale. There is no financial data, no regulatory filing references beyond a mention of the company's Annual Report on Form 10-K for risk disclosures, and no indication that this is a report or a regulatory filing itself. The content focuses on a corporate acquisition announcement, which fits the category of M&A Activity filings. The document length is about 5000 characters, which is consistent with a typical announcement rather than a full report. Therefore, the appropriate classification is M&A Activity (TAR).
2009-10-05 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to on-market share repurchases by ResMed Inc. It provides details on the number of shares bought back, total consideration paid, prices, and compliance statements. The document is short (2239 characters) and focuses on reporting share repurchase activity rather than financial results or management commentary. This matches the description of a 'Transaction in Own Shares' filing, which reports company buyback activities. It is not an announcement of a report, nor a full financial report, nor a regulatory certification. Therefore, the correct classification is POS (Transaction in Own Shares).
2009-10-01 English
Form 8-K Amended Facility Agreement 5 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated September 30, 2009, for ResMed Inc. It reports the entry into a material definitive agreement, specifically the Second Amended and Restated Syndicated Facility Agreement, which is a loan facility amendment and extension. The document details the terms of the loan, interest rates, covenants, and guarantees. The focus is on financing activities and the creation of a direct financial obligation. There are no financial statements or earnings data presented, nor is this an announcement of a report publication. The content clearly relates to updates on company fundraising and capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2009-10-01 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to on-market share repurchases by ResMed Inc. It provides details on the number of shares bought back, total consideration paid, highest and lowest prices paid, and compliance statements. The document is a regulatory notice about share repurchase activity rather than a full financial report or earnings release. It fits the description of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. The document length is short and focused solely on buy-back information, confirming it is not an annual or interim report or other types of filings.
2009-09-30 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.